Equitas's ₹218 crore PAT and 1.31% ROA are encouraging, while NIM fell 55bp to 6.69%. The credit-cost comparison should exclude ARC effects; CEO…
Recovery is material; NIM fell QoQ.
Watch: ROA, adjusted credit cost, funding and successor approval.
Home / Research / Equitas Small Finance Bank
Equitas's ₹218 crore PAT and 1.31% ROA are encouraging, while NIM fell 55bp to 6.69%. The credit-cost comparison should exclude ARC effects; CEO succession is another execution hinge. Compare with Ujjivan and Jana on recurring credit cost and secured portfolio economics. The raised FY27 ROA ambition is a measurable delivery…
Existing Q2 FY27 report; original issuer/exchange source register and limitations in full research.
Existing Q2 FY27 report; original issuer/exchange source register and limitations in full research.
Existing Q2 FY27 report; original issuer/exchange source register and limitations in full research.
SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified):
Recovery is material; NIM fell QoQ.
Watch: ROA, adjusted credit cost, funding and successor approval.
Funding trails credit.
Watch: Review the dated investment thesis and monitoring tests in the full report.
Guidance not actual; Q2 ROA 1.31%.
Watch: Review the dated investment thesis and monitoring tests in the full report.
Five same-basis quarterly profit observations, Sep 2025–Sep 2026. This historical series may differ from bank-only figures in the decision summary; no mixing of reporting bases.
Watch: Separate recurring earnings from one-offs; check the original filings before valuation.
SAGE PRO | 16 November 2026 | Available-source research | WATCH / conditional research stance
Equitas's ₹218 crore PAT and 1.31% ROA are encouraging, while NIM fell 55bp to 6.69%. The credit-cost comparison should exclude ARC effects; CEO succession is another execution hinge. Compare with Ujjivan and Jana on recurring credit cost and secured portfolio economics. The raised FY27 ROA ambition is a measurable delivery test.
PAT ₹218 crore vs ₹24 crore YoY; advances +30%, deposits +19%; ROA 1.31%.
Key takeaways
Capital 11/15: CRAR 20.92%, CD ratio 90.53%, Tier 2 issue supports capital. Risk 6/10: credit cycle and transition.
NIM 6.69% vs 7.24%; adjusted credit cost 1.12%; CEO transition.
ROA, adjusted credit cost, funding and successor approval.
Key takeaways
Evidence scope: TRANSCRIPT_ONLY; confidence MEDIUM. Independent statutory, peer-valuation and forward-model reconciliation remains incomplete. The sector comparison is shared; the opening analysis is issuer-specific.\n\n---\n\n
Key takeaways
The CEO succession process is a separate execution dependency.
Bull case — conditional: Lower fresh microfinance and vehicle slippages allow genuine recurring credit costs to decline, stronger deposits improve funding stability, and operating earnings cover customer-acquisition costs. The 1.35% ROA aspiration becomes credible only when achieved through sustainable spreads and cash collections rather than temporary sale/recovery credits.
Base case — conditional: A rapid loan-book expansion preserves fee/interest growth but liability repricing and a larger secured mix constrain NIM. Underlying profitability improves gradually and the succession transition proceeds without changing underwriting discipline. No assumed 1.35% ROA is booked as a fact.
Bear case — conditional: Loan growth outpaces deposits, credit costs rise when ARC-related benefits fade, or successor uncertainty disrupts deposit mobilization. A 6.69% NIM trending lower while operating costs rise could offset the strong year-on-year PAT rebound.
Next quarter: Ask for ex-ARC credit-cost reconciliation, PAR/early delinquency by vintage, deposit growth on identical bases, NIM, CASA and leadership/regulatory milestones. A current stock target is not implied by these scenarios.
Key takeaways
Equitas's ₹218 crore PAT and 1.31% ROA are encouraging, while NIM fell 55bp to 6.69%. The credit-cost comparison should exclude ARC effects; CEO succession is another execution hinge. Compare with Ujjivan and Jana on recurring credit cost and secured portfolio economics. The raised FY27 ROA ambition is a measurable delivery test.
What the report says: Recovery is material; NIM fell QoQ.
Next observation: ROA, adjusted credit cost, funding and successor approval.
PAT YoY (₹ cr)
| Observation | Existing figure |
|---|---|
| Prior year | 24 |
| Current | 218 |
*Original chart source/basis:* Existing Q2 FY27 report; original issuer/exchange source register and limitations in full research.
Funding trails credit.
What the report says: Funding trails credit.
Next observation: Review the dated investment thesis and monitoring tests in the full report.
Growth (%)
| Observation | Existing figure |
|---|---|
| Advances | 30 |
| Deposits | 19 |
*Original chart source/basis:* Existing Q2 FY27 report; original issuer/exchange source register and limitations in full research.
Guidance not actual; Q2 ROA 1.31%.
What the report says: Guidance not actual; Q2 ROA 1.31%.
Next observation: Review the dated investment thesis and monitoring tests in the full report.
FY27 ROA guidance (%)
| Observation | Existing figure |
|---|---|
| Previous | 1.2 |
| Revised | 1.35 |
*Original chart source/basis:* Existing Q2 FY27 report; original issuer/exchange source register and limitations in full research.
Standalone profit: ₹24.0 cr to ₹218.0 cr over five quarters
What the report says: Five same-basis quarterly profit observations, Sep 2025–Sep 2026. This historical series may differ from bank-only figures in the decision summary; no mixing of reporting bases.
Next observation: Separate recurring earnings from one-offs; check the original filings before valuation.
Quarterly net profit · Standalone (₹ cr)
| Observation | Existing figure |
|---|---|
| Sep 25 | 24.0 |
| Dec 25 | 90.0 |
| Mar 26 | 213.0 |
| Jun 26 | 184.0 |
| Sep 26 | 218.0 |
*Original chart source/basis:* SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified):
Separate profit recovery from a low or negative comparison base
What the report says: Each bar is current-quarter net profit minus same-quarter prior-year net profit in ₹ crore, not a percentage. Negative values indicate deterioration. Same reporting basis throughout.
Next observation: Review the source report for provisions, treasury and exceptional items before extrapolating.
YoY absolute profit change · Standalone (₹ cr)
| Observation | Existing figure |
|---|---|
| Sep 25 | 11.0 |
| Dec 25 | 24.0 |
| Mar 26 | 171.0 |
| Jun 26 | 408.0 |
| Sep 26 | 194.0 |
*Original chart source/basis:* Calculated from SAGE PRO dated canonical research snapshot, current/prior observations: ;
Four-quarter earnings reduce reliance on a single result
What the report says: Trailing four-quarter sum of same-basis net profit; no annualization, adjustment or forecast. Only contiguous four-quarter windows are plotted.
Next observation: Check whether the trailing trend is supported by recurring NII, fee income, funding and credit costs.
Trailing four-quarter net profit · Standalone (₹ cr)
| Observation | Existing figure |
|---|---|
| Sep 25 | -92.0 |
| Dec 25 | -68.0 |
| Mar 26 | 103.0 |
| Jun 26 | 511.0 |
| Sep 26 | 705.0 |
*Original chart source/basis:* Calculated from SAGE PRO dated canonical research snapshot:
Reported ROA is close to the revised FY27 ambition
What the report says: Quarterly ROA 1.31%, revised FY27 guidance 1.35%. Guidance is conditional and uses the issuer's annualised reporting basis.
Next observation: Track credit costs, deposit funding and NIM.
ROA: reported versus management guidance (%)
| Observation | Existing figure |
|---|---|
| Q2 actual | 1.31 |
| FY27 guidance | 1.35 |
*Original chart source/basis:* Existing SAGE PRO Q2 FY27 issuer-specific available-source assessment; original issuer/exchange evidence retained in the report source ledger. Any derived value is explicitly identified.
EQUITASBNK: compare credit growth with relevant lenders
What the report says: Reported loan or advances growth, with issuer-specific gross/net and perimeter differences. FCNR/IBU and IBPC effects are included where the issuer's headline does; do not treat this as normalized organic growth.
Next observation: Reconcile comparable organic growth and funding before peer valuation.
Q2 FY27 reported loan/advance growth YoY · Selected small finance banks (%)
| Observation | Existing figure |
|---|---|
| AUBANK | 25 |
| EQUITASBNK (company) | 30 |
| SURYODAY | 34.6 |
| UJJIVANSFB | 32.1 |
| UTKARSHBNK | 7.5 |
*Original chart source/basis:* SAGE PRO banking sector research and the listed issuers' Q2 FY27 published evidence registers. Reported observations; not independent standardized peer reconciliation.
EQUITASBNK: compare deposit growth with relevant lenders
What the report says: Reported year-on-year deposit growth as disclosed; definitions and special foreign-currency flows may differ. Not a common-perimeter deposit-beta comparison.
Next observation: Examine granular deposits and the cost of incremental funding.
Q2 FY27 reported deposit growth YoY · Selected small finance banks (%)
| Observation | Existing figure |
|---|---|
| AUBANK | 29 |
| EQUITASBNK (company) | 19 |
| SURYODAY | 35 |
| UJJIVANSFB | 29.2 |
| UTKARSHBNK | 7 |
*Original chart source/basis:* SAGE PRO banking sector research and the listed issuers' Q2 FY27 published evidence registers. Reported observations; not independent standardized peer reconciliation.
Compare the earnings scale and momentum on a like-for-like reporting basis
What the report says: Selected banks are compared using the same period and reporting basis (standalone or consolidated). Absolute changes avoid misleading percentage growth from losses or low bases. Profit size also reflects scale, not efficiency; these are not ROA comparisons.
Next observation: Use the peer evidence alongside asset quality, funding and return metrics; cross-check historical figures with issuer filings before investment.
Q2 FY27 net profit · Standalone · Selected bank peers (₹ cr)
| Observation | Existing figure |
|---|---|
| AUBANK | 858.0 |
| UJJIVANSFB | 365.0 |
| EQUITASBNK (company) | 218.0 |
| JSFB | 170.0 |
| ESAFSFB | 160.0 |
| SURYODAY | 77.0 |
| UTKARSHBNK | -70.0 |
*Original chart source/basis:* SAGE PRO dated canonical research financial snapshots; same reporting basis and quarter, secondary historical sources (not independently reverified). Calculated as labeled. AUBANK: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified): | EQUITASBNK: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified): | ESAFSFB: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified): | JSFB: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified): | SURYODAY: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified): | UJJIVANSFB: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified): | UTKARSHBNK: SAGE PRO dated canonical research financial snapshot; secondary historical source (not independently reverified):
Key takeaways
Calculated from SAGE PRO dated canonical research snapshot, current/prior observations: ;
Calculated from SAGE PRO dated canonical research snapshot:
Existing SAGE PRO Q2 FY27 issuer-specific available-source assessment; original issuer/exchange evidence retained in the report source ledger. Any derived value is explicitly identified.
SAGE PRO banking sector research and the listed issuers' Q2 FY27 published evidence registers. Reported observations; not independent standardized peer reconciliation.
This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.